Nektar TherapeuticsEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 70.725 USD | 109 USD | 21,02 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 153,222 USD | 2 | 2 | 3 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 33.786.032 | 22,52 | 5,42 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Nektar Therapeutics
Mitarbeiter 63
Handelsplatz NASDAQ
Ticker Symbol NKTR
IPO Datum 1994-05-03
Adresse 455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158
Webseite https://www.nektar.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Howard W. Robin | CEO, President & Director |
| 2 | Dr. Jonathan Zalevsky Ph.D. | Senior VP and Chief Research & Development Officer |
| 3 | Ms. Linda M. Rubinstein M.A. | CFO and Principal Financial & Accounting Officer |
| 4 | Mr. Jason Barnard | Chief Accounting Officer |
| 5 | Ms. Elizabeth Zhang | VP of Legal, Corporate Counsel & Secretary |
| 6 | Mr. Robert Bacci | Chief People Officer and Head of Quality & Facilities |
| 7 | Ms. Jennifer Ruddock | Chief Business Officer |
| 8 | Dr. Mary Tagliaferri L.Ac., M.D. | Chief Medical Officer |
| 9 | Dr. Ken Franke Ph.D. | Senior Vice President of Biologics Process Development & Manufacturing |
| 10 | Ms. Charleen Jue | Senior Vice President of Clinical Development Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | Bvf Inc | 0,00% | 0,00 Mio. USD |
| 3 | Two Seas Capital LP | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 6 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 7 | Prosight Management, LP | 0,00% | 0,00 Mio. USD |
| 8 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 9 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 10 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 12 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 13 | Sofinnova Ventures | 0,00% | 0,00 Mio. USD |
| 14 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 15 | Lord, Abbett & Co LLC | 0,00% | 0,00 Mio. USD |
| 16 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 17 | Emerald Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 19 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 20 | UBS Group AG | 0,00% | 0,00 Mio. USD |